Deborah Watkins Bruner
#178,501
Most Influential Person Now
Researcher
Deborah Watkins Bruner's AcademicInfluence.com Rankings
Download Badge
Nursing
Deborah Watkins Bruner's Degrees
- PhD Nursing University of California, San Francisco
- Masters Nursing University of California, San Francisco
- Bachelors Nursing University of California, San Francisco
Why Is Deborah Watkins Bruner Influential?
(Suggest an Edit or Addition)According to Wikipedia, Deborah Watkins Bruner is an American researcher, clinical trialist, and academic. She is the senior vice president for research at Emory University. Her research focus is on patient reported outcomes, symptom management across cancer sites, sexuality after cancer treatment, and effectiveness of radiotherapy modalities. Bruner's research has been continually funding since 1998, with total funding of her research exceeding $180 million. She is ranked among the top five percent of all National Institutes of Health-funded investigators worldwide since 2012, according to the Blue Ridge Institute for Medical Research.
Deborah Watkins Bruner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. (2005) (731)
- Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). (2015) (703)
- Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). (2014) (677)
- Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. (2011) (660)
- Radiotherapy and short-term androgen deprivation for localized prostate cancer. (2011) (495)
- Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer. (2016) (410)
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (2020) (326)
- Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. (2016) (287)
- Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. (2014) (281)
- A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment (2013) (233)
- Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial (2018) (211)
- Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. (2018) (180)
- Patterns and risk factors associated with aromatase inhibitor‐related arthralgia among breast cancer survivors (2009) (166)
- Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. (2009) (166)
- Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (2013) (148)
- PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) (2010) (147)
- Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial (2018) (146)
- Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. (2007) (133)
- Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. (2013) (126)
- Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor‐related arthralgia: A randomized trial (2014) (110)
- Development and Initial Validation of the PROMIS(®) Sexual Function and Satisfaction Measures Version 2.0. (2015) (110)
- Comparison Between Patient-Reported and Clinician-Observed Symptoms in Oncology (2013) (105)
- A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use. (2014) (96)
- Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. (2015) (87)
- Radiation Therapy Oncology Group (RTOG). (1996) (83)
- Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. (2013) (78)
- Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. (2007) (77)
- Composition of gut microbiota and its association with body mass index and lifestyle factors in a cohort of 7–18 years old children from the American Gut Project (2018) (76)
- Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. (2017) (74)
- Preservation of Neurocognitive Function (NCF) with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (HA-WBRT) for Brain Metastases: Preliminary Results of Phase III Trial NRG Oncology CC001 (2018) (72)
- Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer. (2012) (70)
- Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2011) (67)
- Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. (2012) (64)
- Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. (2005) (64)
- Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy (2016) (62)
- Prevalence and correlates of vitamin D status in African American men (2009) (62)
- Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. (2014) (61)
- Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study. (2020) (60)
- Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. (2008) (54)
- Preliminary patient‐reported outcomes analysis of 3‐dimensional radiation therapy versus intensity‐modulated radiation therapy on the high‐dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial (2015) (53)
- Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study (2007) (52)
- Electronic Toxicity Monitoring and Patient-Reported Outcomes (2011) (51)
- The impact on quality of life by radiation late effects. (1995) (51)
- Feasibility Trial of Electroacupuncture for Aromatase Inhibitor—Related Arthralgia in Breast Cancer Survivors (2009) (50)
- A literature review of symptom clusters in patients with breast cancer (2011) (48)
- Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device. (2015) (47)
- Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2019) (47)
- Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial. (2020) (46)
- Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2020) (45)
- Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. (2014) (44)
- Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. (2018) (43)
- Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048. (2018) (42)
- Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. (2006) (42)
- The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial (2022) (40)
- Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. (2014) (39)
- Construct validity of the PROMIS® sexual function and satisfaction measures in patients with cancer (2013) (38)
- NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer. (2016) (38)
- RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: implications for improving patient recruitment. (2010) (38)
- Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? (2007) (38)
- Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. (2011) (37)
- A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. (2017) (36)
- Spirituality and Quality of Life in Black Patients With Cancer Pain. (2018) (36)
- Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial (2019) (34)
- 1842676957299765Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities (2009) (34)
- An integrative review of guidelines for anal cancer screening in HIV-infected persons. (2014) (33)
- NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in patients with brain metastases (BM). (2019) (33)
- Research Participation Among Asian American Women at Risk for Cervical Cancer: Exploratory Pilot of Barriers and Enhancers (2011) (32)
- A Phase III Randomized Trial Comparing Patient-Reported Toxicity and Quality of Life (QOL) During Pelvic Intensity Modulated Radiation Therapy as Compared to Conventional Radiation Therapy. (2016) (32)
- The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review (2018) (31)
- Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model (2004) (31)
- Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE). (2010) (30)
- Expectancy in real and sham electroacupuncture: does believing make it so? (2014) (29)
- Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP). (2018) (29)
- Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. (2017) (28)
- The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial (2014) (26)
- Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials (2012) (26)
- Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer (2018) (25)
- Risk factors for clinician‐reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129 (2014) (25)
- Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial (2017) (24)
- The sexual impact of cancer and cancer treatments in men. (2007) (24)
- NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001 (2018) (23)
- A pilot study to identify correlates of intentional versus unintentional nonadherence to analgesic treatment for cancer pain. (2013) (22)
- Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study (2014) (22)
- Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers (2020) (22)
- NRG Oncology RTOG 0415: A Randomized Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer (2016) (22)
- Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. (2017) (22)
- Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial. (2022) (22)
- Capturing the patient perspective: patient-reported outcomes as clinical trial endpoints. (2012) (21)
- Patient-Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase 2 Study Evaluating 2 Ultrahypofractionated Regimens (UHRs) for Prostate Cancer (2016) (21)
- Factors Related to Adherence to Opioids in Black Patients With Cancer Pain. (2019) (20)
- Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: a feasibility study of late toxicity. (2014) (19)
- The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms (2020) (18)
- Prostate cancer elder alert. Living with treatment choices and outcomes. (2000) (18)
- Benchmarking and gap analysis of faculty mentorship priorities and how well they are met. (2016) (18)
- Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study (2021) (17)
- 79 Correlation of quality of life (QOL) with survival, treatment response, and anemia in patients with advanced non-small cell lung cancer (NSCLC) treated with carboplatin and paclitaxel (1997) (17)
- Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model. (2007) (17)
- Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer (2018) (16)
- Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714. (2008) (16)
- Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. (2019) (15)
- Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: a feasibility study with ultrasound B-mode and Nakagami parameter imaging. (2013) (15)
- Validation of the sexual adjustment questionnaire (SAQ) in prostate cancer patients enrolled on radiation therapy oncology group (RTOG) studies 90-20 and 94-08 (1998) (15)
- MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL (2019) (15)
- Validation of a Predictive Model for Survival in Patients With Advanced Cancer: Secondary Analysis of RTOG 9714 (2011) (14)
- Patient Reported Outcomes of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone in Intermediate Risk Prostate Cancer (2018) (14)
- Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. (2019) (14)
- Prostate Cancer Risk Assessment Program (1999) (14)
- Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study (2017) (14)
- Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials—an NRG Oncology RTOG Study (2017) (14)
- Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline (2022) (13)
- Feasibility trial of electro-acupuncture for aromatase inhibitor related arthralgia in breast cancer survivors. (2009) (13)
- Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy. (2014) (13)
- In search of the "quality" in quality-of-life research. (1995) (13)
- Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials. (2015) (13)
- Perceptions and practices regarding women's vaginal health following radiation therapy: A survey of radiation oncologists practicing in the United States. (2017) (13)
- Dose Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Suppression for Intermediate Risk Prostate Cancer: Outcomes From the NRG Oncology/RTOG 0815 Randomized Trial. (2021) (12)
- Methods for examining cancer symptom clusters over time. (2014) (11)
- Using focus groups to adapt ethnically appropriate, information-seeking and recruitment messages for a prostate cancer screening program for men at high risk. (2008) (11)
- Comparison of vaginal microbiota in gynecologic cancer patients pre‐ and post‐radiation therapy and healthy women (2019) (11)
- Predictors of preferences and utilities in men treated with 3D-CRT for prostate cancer. (2004) (10)
- Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. (2021) (9)
- The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy. (2018) (9)
- Pilot study of combined aerobic and resistance exercise on fatigue for patients with head and neck cancer: Inflammatory and epigenetic changes (2020) (8)
- Randomized Phase 2 Trial of Best Supportive Care: Manuka Honey Liquid and Manuka Honey Lozenges for Prevention of Radiation Esophagitis During Chemotherapy and Radiation Therapy for Lung Cancer (2014) (8)
- IMRT Improves Late Toxicity Compared to Conventional RT: An Update on NRG Oncology-RTOG 1203 (2019) (7)
- Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials. (2020) (7)
- NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results (2016) (7)
- Funding patient-reported outcomes in cancer clinical trials. (2007) (6)
- Confirmatory factor analysis of brief pain inventory (BPI) functional interference clusters in patients with bone metastases. (2010) (6)
- RESPONSE: Re: Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases (2006) (5)
- RTOG 0841: Two-Item Questionnaire Effectively Screens for Depression in Cancer Patients Receiving Radiation Therapy (2013) (5)
- Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer (2020) (5)
- Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial. (2021) (5)
- Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. (2018) (5)
- WE‐C‐BRA‐10: Ultrasound Nakagami Imaging for Noninvasive Evaluation of Vaginal Fibrosis Following Radiotherapy for Gynecologic Malignancies (2012) (5)
- The identification and screening of men at high risk for developing prostate cancer. (2000) (5)
- Gut Microbiome and Its Associations With Acute and Chronic Gastrointestinal Toxicities in Cancer Patients With Pelvic Radiation Therapy: A Systematic Review (2021) (5)
- Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study (2019) (5)
- Factor Analysis of the Modified Sexual Adjustment Questionnaire-Male (2014) (4)
- Significant Preservation of Neurocognitive Function (NCF) and Patient-Reported Symptoms with Hippocampal Avoidance (HA) during Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Final Results of Nrg Oncology CC001 (2019) (4)
- Model quality assurance program for radiation oncology nursing (1990) (4)
- Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126 (2022) (4)
- Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial. (2021) (4)
- Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers (2021) (4)
- 1053 Preservation of sexual function in young prostate cancer patients after radiation therapy: A positive factor in choice of a treatment modality (1996) (4)
- A Pragmatic Evaluation of the National Cancer Institute Physician Data Query (PDQ)®-Based Brief Counseling on Cancer-Related Fatigue among Patients Undergoing Radiation Therapy (2012) (4)
- Nurse scientists in cancer cooperative groups. (2014) (4)
- Preliminary Analysis of 3D-CRT vs. IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Patient Reported Outcomes (2011) (4)
- ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001 (2019) (3)
- A network analysis of self‐reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity‐modulated radiotherapy (2022) (3)
- Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery (2016) (3)
- An experience with the Patient-Reported Outcomes Measurement Information System: pros and cons and unanswered questions. (2014) (3)
- Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer (2012) (3)
- Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification. (2017) (3)
- Do reminder emails and past due notifications improve patient completion and institutional data submission for patient-reported outcome measures? (2020) (3)
- How Nurse Scientists Can Stay Productive and On Track During the Pandemic (2020) (3)
- Translational Research Program (2001) (3)
- Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415 (2021) (3)
- Factors Associated with Depression in African American Patients Being Treated for Cancer Pain. (2020) (3)
- A Comparison of Missing-Data Imputation Techniques in Exploratory Factor Analysis (2019) (3)
- PCN16: VALIDITY OF THE TIME-TRADE OFF TECHNIQUE IN DETERMINING PREFERENCES FOR THE TREATMENT OF PROSTATE CANCER (2000) (2)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. (2001) (2)
- Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review (2022) (2)
- Composite grading algorithm for National Cancer Institute’s PRO-CTCAE. (2020) (2)
- Cultural Competency Training to Increase Minority Enrollment into Radiation Therapy Clinical Trials—an NRG Oncology RTOG Study (2016) (2)
- 179 Long term quality of life study in prostate cancer patients treated with three dimensional conformal radiation therapy: Bowel and bladder quality of life symptoms are similar to that of the normal population (1999) (2)
- Determination of preferences and utilities for the treatment of prostate cancer (1999) (2)
- Prospective International Pilot Study Evaluating the Efficacy of a Self-Guided Contouring Teaching Module With Integrated Feedback for Transitioning From 2D to 3D Treatment Planning (2019) (2)
- Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP). (2016) (2)
- Abstract PD4-7: A randomized placebo-controlled trial of acupuncture and gabapentin for hot flashes among breast cancer survivors (2015) (2)
- RADI-11. NRG ONCOLOGY CC001: A PHASE III TRIAL OF HIPPOCAMPAL AVOIDANCE IN ADDITION TO WHOLE-BRAIN RADIOTHERAPY (WBRT) PLUS MEMANTINE TO PRESERVE NEUROCOGNITIVE FUNCTION IN PATIENTS WITH BRAIN METASTASES (BM) (2019) (2)
- Adherence trajectories in oral therapy for chronic myeloid leukemia: Overview of a research protocol. (2020) (2)
- Quality of Life and Cost Effectiveness Outcomes of Androgen Deprivation Therapy for Prostate Cancer (1997) (2)
- NRG Oncology/RTOG 0415, Hypofractionation in Patients with Low-Risk Prostate Cancer: Are Patient Reported Outcomes the Practice Change Tipping Point? (2017) (1)
- Do subjective measures of adherence predict actual analgesic taking behavior for cancer pain (2011) (1)
- Breast cancer patients have better outcomes than prostate cancer patients for palliation of painful bone metastases: Results of RTOG 97–14 (2005) (1)
- Gynecologic cancer treatment toxicities and relationships with the vaginal microbiome (2021) (1)
- Decline in Tested and Patient-reported Cognitive Functioning Following Prophylactic Cranial Irradiation for Lung Cancer: Secondary Analysis of RTOG 0212 and 0214 (2011) (1)
- A Prospective International Pilot Study Evaluating the Efficacy of a Self-Guided Contouring Teaching Module with Integrated Feedback for Transitioning from 2D to 3D Treatment Planning (2019) (1)
- Does enrollment setting influence patient attributes and outcomes in RTOG prostate cancer trials? (2011) (1)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. (2001) (1)
- Prognostic significance of QOL deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214. (2011) (1)
- Determination of Prognostic Factors for Long-term Vaginal Toxicity Associated with Intravaginal High-dose Rate Brachytherapy in Patients with Endometrial Carcinoma (2010) (1)
- 2296 Men treated with radiotherapy have better global quality of life outcomes despite decrements in site-specific quality of life domains than men at increased risk but without prostate cancer (1999) (1)
- Functional disability and aromatase inhibitor-associated arthralgia in breast cancer survivors. (2010) (1)
- CN3 BEHIND THE VEIL OF IGNORANCE: ASSESSMENT OF PREFERENCES AND UTILITIES FROM MEN AT-RISK FOR PROSTATE CANCER (2002) (1)
- Quality of Life (QOL) Supercedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC): An Analysis of Radiation Therapy Oncology Group (RTOG) 9801 (2007) (1)
- Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial (2022) (1)
- Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer (2015) (1)
- Group organizational structure (2001) (1)
- An economic analysis of Radiation Therapy Oncology Group 94-10: cost-efficacy of concurrent vs. sequential chemoradiotherapy (2018) (1)
- Screening for depression in community-based radiation oncology settings: Results from RTOG 0841. (2013) (1)
- Factors associated with willingness to participate in an acupuncture clinical trial for arthralgia among breast cancer patients. (2009) (1)
- Automated segmented field selection for IMRT using utility based decision theory (1998) (1)
- How to Maintain a Healthy Gut Microbiome in Children with Cancer? Gut Microbiome Association with Diet in Children with Solid Tumors Postchemotherapy. (2022) (1)
- Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer--reply. (2014) (1)
- NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in Patients With Brain Metastases (BM) (2019) (1)
- 2150 Screening with free PSA benefits men at high risk of developing prostate cancer (1999) (1)
- Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (2015) (1)
- WE-E-134-03: Ultrasonic Tissue Characterization of Parotid-Gland Injury Following Head-And-Neck Radiotherapy Using Nakagami-Parameter Imaging: A Feasibility Study. (2013) (1)
- Epigenetic Mechanisms of Inflammation and Fatigue in Patients With Cancer (2018) (1)
- Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities (2018) (1)
- Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial. (2021) (1)
- Prostate cancer elder alert. Epidemiology, screening, and early detection. (2000) (1)
- Genitourinary cancer committee (2001) (1)
- Abstract PO-033: Metabolic differences between human papillomavirus-related and smoking-related squamous cell carcinoma of the head and neck independently predict overall patient survival (2020) (0)
- Abstract #4314 Pilot study of combined aerobic resistance exercise on fatigue and inflammation for patients with head and neck cancer (2019) (0)
- Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1 (2019) (0)
- Persistent Fatigue Is Associated With Persistent Peripheral Inflammation in Patients With Squamous Cell Carcinoma of the Head and Neck Cancer up to 3 Months Post-Intensity Modulated Radiation Therapy (2016) (0)
- Obesity and patient-reported sexual health outcomes in gynecologic cancer survivors: A systematic review. (2022) (0)
- Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841. (2021) (0)
- Changes in Physical Activity and Psychological Factors Among Breast Cancer Survivors Enrolled in a YMCA Program (2015) (0)
- Design Challenges in Palliative Radiation Oncology Clinical Trials (2013) (0)
- Abstract 3214: Associations of socioeconomic status and gut microbiome with psychoneurological symptom cluster in gynecologic cancer patients (2023) (0)
- Abstract 2418: Are we underestimating cancer mortality? A mediation model shows a larger impact from smoking (2019) (0)
- Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials (2020) (0)
- PCN109 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) (2010) (0)
- Longitudinal predictive ability of mapping algorithms: Secondary analysis of NRG Oncology/RTOG 0415. (2021) (0)
- Neighborhood Deprivation and Rurality Associated with Patient-Reported Outcomes and Survival in Men with Prostate Cancer in NRG RTOG 0415. (2023) (0)
- Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials (2020) (0)
- 0577 Sleep Quality and Its Association with Inflammation Over Time in Patients Undergoing Radiation Therapy for Head and Neck Cancer (2022) (0)
- Exploring the Vaginal Microbiome and Intravaginal Practices in Postmenopausal Women (2021) (0)
- Progesterone to improve neurocognitive outcomes following cranial irradiation. (2016) (0)
- Associations between Dietary Intakes and the Gut Microbiome in Children with Solid Tumors after Chemotherapy and Healthy Controls (2021) (0)
- 07 / A COMPARISON OF QUALITY OF LIFE, SEXUAL FUNCTION AND DEPRESSION BETWEEN WOMEN WITH GYNECOLOGICAL CANCERS AND RACE-MATCHED HEALTHY CONTROLS (2018) (0)
- Electro-acupuncture for joint pain related to aromatase inhibitors among breast cancer survivors: A randomized placebo-controlled trial. (2013) (0)
- PCNI9: QUALITY OF LIFE PROFILE OF MEN AT-RISK FOR PROSTATE CANCER:THE FIT AND THE WORRIED WELL (2003) (0)
- 115 : The Addition of Chemotherapy to Radiation Is Cost-Effective in the Treatment of Patients With Locally Advanced Laryngeal Cancer: An Economic Analysis of Radiation Therapy Oncology Group (RTOG) 91-11 (2006) (0)
- Preliminary results of RTOG 0831, a randomized, double-blinded, placebo-controlled trial of tadalafil in the prevention of erectile dysfunction in patients treated with radiotherapy for prostate cancer. (2013) (0)
- Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival (2021) (0)
- 2295 Quality of life (FACT-C) scores remain at baseline following conformal radiotherapy for prostate cancer: A prospective study (1999) (0)
- RTOG 0215 Treatment of Erectile Dysfunction (ED) in Patients Treated With Neoadjuvant and Concurrent Androgen Deprivation (AD) and Radiotherapy (RT) for Prostate Cancer (PC) (2007) (0)
- Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial RTOG 0415 (2019) (0)
- VIVO ASSESSMENT OF THE THERAPEUTIC EFFECTS OF LYOPHILIZED LEECH SALIVA EXTRACT FROM ( Huridinaria manillensis ) ON DIFFERENT TUMOR XENOGRAFT MODELS IN NUDE MICE (2014) (0)
- Abstract 2528: Rurality and neighborhood socioeconomic deprivation associated with patient-reported outcomes andsurvivalin men with prostate cancer in NRG RTOG 0415 (2021) (0)
- 119 : Predictors of Late Toxicities and Symptom Clusters in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials of High Risk Patients: A Meta-Analysis of Physician Rated Toxicities (2006) (0)
- Multiparametric Ultrasound Imaging of Vaginal Fibrosis Following Radiation Therapy for GYN Malignancies (2013) (0)
- A Qualitative Study of the Pain Experience of Black Individuals With Cancer Taking Long-Acting Opioids. (2023) (0)
- (385) Opiate adherence in African Americans being treated for cancer pain. (2016) (0)
- Demystifying radiation oncology. (1996) (0)
- Abstract 6731: Gut microbiome associated with the psychoneurological symptom cluster among children with solid tumors receiving chemotherapy (2023) (0)
- “Less is not Always more”: An Economic Analysis of Radiation Therapy Oncology Group 94–10 (2007) (0)
- The Relationship Between Body Mass Index and Sexual Function in Endometrial Cancer . (2018) (0)
- Predictors on Longitudinal Changes of Clinician Reported Symptom Clusters Identified in Patients with Head and Neck Cancer Treated on RTOG Trials (2011) (0)
- Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. (2023) (0)
- Onset and risk factors for aromatase inhibitor-related arthralgia in breast cancer survivors. (2009) (0)
- HPV status is associated with fatigue and inflammation in patients with squamous cell carcinoma of the Head and Neck from pre to up to 3 Months Post IMRT (2017) (0)
- A methodological comparison of mapping algorithms to obtain health utilities derived using cross-sectional and longitudinal data: Secondary analysis of NRG/RTOG 0415. (2020) (0)
- Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415. (2022) (0)
- IMRT-Induced Acute Fatigue in Patients with Head and Neck Cancer: A Prospective Study (2014) (0)
- Prevalence and Risk Factors for Insomnia in Breast Cancer Survivors Receiving Aromatase Inhibitors. (2009) (0)
- Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood. (2021) (0)
- Abstract 4257: Predicting fatigue levels of head and neck cancer patients with gene expression using machine learning (2018) (0)
- When Patience is a Failing: The Case for Patient Reported Outcomes Adoption. (2023) (0)
- Promoting Cancer Health Equity in Research (2020) (0)
- Comment on: Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. Authors' reply (2006) (0)
- Medulla Dose is Positively Associated with Sensation of Thirst & Midbrain Dose is Inversely Associated with Pain: Prospectively-Collected Patient-Reported Toxicities and Brainstem Dose in Head and Neck Cancer Radiation Therapy (2018) (0)
- Editorial: death to the fiefdoms. (2012) (0)
- Prostate screening programs hosted by radiation oncologists: Feasibility and outcome (1995) (0)
- African Americans are more likely to receive an analgesic with toxic metabolite despite clinical risks (2012) (0)
- Increased Fatigue Is Associated With TNF and NFκB-Regulated Inflammatory Signaling in Patients With Head and Neck Cancer Receiving IMRT (2014) (0)
- Patient Reported Outcomes Measurement Information System® Sexual Function and Satisfaction (2017) (0)
- Trajectories of sexual dysfunction and its risk factors in women with gynecologic cancer across radiation therapy and healthy controls. (2020) (0)
- Gene expression changes and fatigue during IMRT in patients with head and neck cancer (2015) (0)
- Quantitative Ultrasound Evaluation of Post-Radiation Therapy Sialadenitis and Fibrosis of the Parotid Glands in Patients Following Head-and-Neck Radiation Therapy (2013) (0)
- Patterns of Missing Mini Mental Status Exam Data in Radiation Therapy Oncology Group (RTOG) Brain Tumor Trials (2008) (0)
- Gerald E. Hanks, MD, FASTRO. (2018) (0)
- Psychosexual support for women with gynecological or breast cancer: improving outcomes (2000) (0)
- Abstract 720: Comparison of the gut microbiome between children with solid tumor receiving chemotherapy and healthy children (2022) (0)
- Follow-Up to High-Resolution Anoscopy After Abnormal Anal Cytology in People Living with HIV. (2022) (0)
- Abstract 500: Neuropsychological symptoms in patients with head and neck cancer undergoing radiation therapy: A network analysis (2022) (0)
- Abstract LB-362: Vaginal microbiome associated with patient-reported sexual dysfunction and physician-reported vaginal adverse events in gynecologic cancer women across radiotherapy (2020) (0)
- Abstract A71: Clinical trial participation: Differences in distance traveled across different ethnic groups (2014) (0)
- Gut Microbiome Associated with Abdominal Pain in Children with Solid Tumors Post-Chemotherapy and Healthy Controls (2021) (0)
- Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer. (2022) (0)
- In Reply to Al-Rashdan. (2021) (0)
- Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood. (2022) (0)
- Reproducibility of an International Contouring Teaching Module for Resident Education (2020) (0)
- Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. (2023) (0)
- Perceptions and Practices Regarding Women’s Vaginal Health Following Radiation Therapy (2014) (0)
- Abstract 5940: Impact of obesity on sexual functioning in women with gynecologic cancer pre-and post-radiotherapy (2022) (0)
- PCN76 IMPACT OF SILDENAFIL ON MARITAL AND SEXUAL ADJUSTMENT IN PATIENTS AND THEIR PARTNERS AFTER RADIOTHERAPY AND SHORT-TERM ANDROGEN SUPPRESSION FOR PROSTATE CANCER: ANALYSIS OF RTOG 0215 (2008) (0)
- SPECIAL SESSION: Advancing Patient Centered Oncology Practice, Advocacy, and Policy (2016) (0)
- PCN25 CASE-MATCHED CONTROLLED STUDY SHOWS MEN PREFER PROSTATE BRACHYTHERAPY TO CONFORMAL RADIATION THERAPY (2004) (0)
- CNS Dose Is Not Associated With Treatment-Related Fatigue in Patients Undergoing Radiation Therapy for Head and Neck Cancer (2016) (0)
- 128. The relationship between inflammation and fatigue development in patients with head and neck cancer receiving IMRT (2014) (0)
- TH-E-BRF-09: Gaussian Mixture Model Analysis of Radiation-Induced Parotid-Gland Injury: An Ultrasound Study of Acute and Late Xerostomia in Head-And-Neck Radiotherapy. (2014) (0)
- PCN21: DIFFERENCES IN HUSBAND/WIFE PREFERENCES AND UTILITIES FOR PROSTATE CANCER THERAPIES (2003) (0)
- PCN1: CATEGORIZATION OF RISK OF PROSTATE CANCER: PILOT TEST OF CLINICAL OUTCOMES AND RISK PERCEPTIONS (2001) (0)
This paper list is powered by the following services:
Other Resources About Deborah Watkins Bruner
What Schools Are Affiliated With Deborah Watkins Bruner?
Deborah Watkins Bruner is affiliated with the following schools:
